Vimarsana
Biggest News Aggregation in the World

Advicenne News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Advicenne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Advicenne Today - Breaking & Trending Today

Avanzanite Bioscience Expands Partnership With Advicenne in Additional European Countries - Vimarsana News

Avanzanite Bioscience Expands Partnership With Advicenne in Additional European Countries

AMSTERDAM, October 18, 2023--Avanzanite's expanded collaboration with Advicenne now includes Ireland, Cyprus and Malta in addition to existing markets (DE, AT, CH, GR, LI).

Source: yahoo.com
Advicenne Announces Long-Term Results of the European Clinical Development Program for ADV7103 - Vimarsana News

Advicenne Announces Long-Term Results of the European Clinical Development Program for ADV7103

Regulatory News: Advicenne(Euronext Growth Paris ALDVI FR0013296746), a specialty pharmaceutical company dedicated to the development and commercialization of innovative treatments for those suffering

Advicenne : Inside Information / Other news releases - Vimarsana News

Advicenne : Inside Information / Other news releases

Advicenne announces the approval of all resolutions supported by the Board of Directors at its Combined General Meeting Paris , June 9, 2023 - 8.00 am CET - The... | June 9, 2023

Advicenne annual combined general meeting of June 8, 2023 - Vimarsana News

Advicenne annual combined general meeting of June 8, 2023

Availability of preparatory documents Regulatory News: Advicenne (Euronext Growth Paris ALDVI FR0013296746)(Paris:ALDVI), a specialty pharmaceutical company dedicated to the development and commercialization

Advicenne Announces the Launch of Sibnayal in Denmark - Vimarsana News

Advicenne Announces the Launch of Sibnayal in Denmark

Sibnayal (potassium citrate/potassium bicarbonate) has been launched on March 1, 2023 Reference price equals to an annual treatment cost of €15,000 per patient. Regulatory News: Advicenne